Awards & Advancement

Ernest Mario named chairman of Chimerix

Wednesday, February 20, 2013 12:25 PM

Chimerix, a Durham, N.C.-based biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, has appointed Ernest Mario, Ph.D., as chairman of its board of directors.

More... »

Xenon appoints Bridger as executive vice president, R&D

Thursday, February 14, 2013 08:00 AM

Xenon Pharmaceuticals, a clinical genetics-based drug discovery and development company focused on rare diseases, has appointed Gary J. Bridger, PhD, as executive vice president of research and development.

More... »

AcelRx appoints Adrian Adams to board

Tuesday, February 12, 2013 08:00 AM

AcelRx Pharmaceuticals, a specialty pharmaceutical company focused on acute and breakthrough pain, has appointed Adrian Adams, CEO and president of Auxilium Pharmaceuticals, to its board of directors as chairman of the board.  

More... »

Recipharm appoints Lennernäs to operating board

Wednesday, February 6, 2013 12:38 PM

Recipharm, a contract development and manufacturing organization based in Sweden, has appointed Dr. Hans Lennernäs to the operating board of Recipharm Pharmaceutical Development.

More... »

Chiltern wins PharmaTimes award

Monday, February 4, 2013 10:23 AM

Chiltern International, a global CRO, has won an award at the PharmaTimes Annual Awards 2012. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

More... »

Novo Nordisk promotes four to senior vice president

Friday, February 1, 2013 02:39 PM

Novo Nordisk, a global healthcare company, has promoted four corporate vice presidents to senior vice presidents. Effective March 1, 2013, the following members of the U.S. executive team will assume the title of senior vice president in their respective areas: Andy Ajello, U.S. national diabetes sales; Camille Lee, U.S. diabetes marketing; Alan Moses, MD, global chief medical officer; and Anne Phillips, MD, U.S. clinical, medical and regulatory affairs.

More... »

Synteract appoints Kelson as CFO, Doren as vice president of biometrics

Wednesday, January 30, 2013 03:18 PM

Synteract, a full service CRO based in Carlsbad, Calif., has hired new executives to support customers on a global scale. Keith Kelson will serve as chief financial officer and member of its executive council, and Phil Doren has been appointed vice president of biometrics.

More... »

CDISC names additions to board of directors

Friday, January 25, 2013 12:27 PM

CDISC, a global, open, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata, has named five highly qualified individuals that will add invaluable expertise to the CDISC board of directors (BoD) for a three-year term beginning this month (2013–2016): Dr. Carolyn Compton, Michael Glickman, Dr. Douglas Peddicord, Stephen Pyke and John Speakman.

More... »

DIA names Stephen P. Spielberg editor-in-chief of TIRS journal

Friday, January 25, 2013 11:59 AM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, announced the arrival of Stephen P. Spielberg, M.D., Ph.D., as editor-in-chief of the newly launched, official DIA peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS).

More... »

Change to the Roche corporate executive committee

Wednesday, January 16, 2013 10:53 AM

Switzerland-based Roche has named John C. Reed, M.D., Ph.D., as its new head of Roche Pharma Research and Early Development (pRED) and member of the enlarged corporate executive committee.

More... »